Skip to main content
. 2019 Apr-Jun;13(2):106–111. doi: 10.4103/sja.SJA_557_18

Table 5.

Attitude toward receiving information about adverse drug reactions of NSAIDs (n=200*)

Items Strongly agree Agree Not sure Disagree Strongly disagree
You need to know about ADRs of medications 111 (66.5) 77 (38.5) 12 (6)
Being informed about ADRs may increase your anxiety 62 (31) 38 (19) 46 (23) 28 (14) 20 (10)
Physicians should have a role to inform you about ADRs 92 (46) 96 (48) 8 (4) - -
Receiving ADR information from healthcare professional may be a waste of time 16 (8) 12 (6) 24 (12) 94 (47) 54 (27)
Pharmacists should play a direct role in providing ADR information 72 (36) 109 (54.5) 11 (5.5) - 8 (4)
Information about ADRs may help you to tell physicians about any abnormal symptoms which occur 66 (33) 108 (54) 26 (13) - -
Information about ADRs may cause you to discontinue medicines 78 (39) 30 (15) 51 (25.5) 32 (16) 9 (4.5)
Healthcare setting provide you insufficient knowledge of ADRs 63 (31.5) 106 (53) 31 (15.5) - -
Provision of information from health professionals and receiving information leaflets can improve your knowledge about medicines 78 (39) 108 (54) 4 (2) 6 (3) 4 (2)
Receiving information leaflets may encourage you to decrease your adherence 31 (15.5) 49 (24.5) 6 (3) 83 (41.5) 31 (15.5)
Information leaflets are an information source which can help you to monitor ADRs and tell health professionals about ADRs 52 (26) 132 (66) 8 (4) 8 (4) -
Information leaflets cannot improve your confidence about safety when using medicines 24 (12) 31 (15.5) 32 (16) 72 (36) 41 (20.5)
Receiving an information leaflet the first time of using a medicine is a necessity 50 (25) 116 (58) 16 (8) 12 (6) 6 (3)
You don’t need information leaflets for all medicines 35 (17.5) 63 (31.5) 24 (12) 50 (25) 28 (14)
Information leaflets that you have read were difficult to understand 20 (10) 63 (31.5) 30 (15) 71 (35.5) 14 (7)
Information leaflets are not reliable information sources for providing medicines’ information for you 37 (18.5) 63 (31.5) 28 (14) 28 (14) 44 (22)
You need to receive information leaflets which are specifically for patients 65 (32.5) 119 (59.5) 8 (4) 6 (3) 2 (1)
If you receive a patient information leaflet, you are confident you will thoroughly read that leaflet 89 (44.5) 103 (51.5) 8 (4)

NSAID: Nonsteroidal anti-inflammatory drug; ADR: Adverse drug reaction. *Numbers and percentage do not add up to total (100%) due to missing data